Search
Autism researcher Professor Andrew Whitehouse has been named this year’s Western Australian of the Year in the HBF Professions category.
New research evaluating the potential cost savings of a therapy for babies displaying early autism signs has predicted a three dollar return to Australia’s National Disability Insurance Scheme (NDIS) for every dollar invested in therapy.
Professor Andrew Whitehouse, who has helped transform clinical support for children on the autism spectrum in Australia, is nominated for WA's 2023 Australian of the Year.
Professor Andrew Whitehouse has been inducted as the youngest-ever Fellow to the Australian Academy of Health and Medical Sciences.
Director of CliniKids, Professor Andrew Whitehouse, and Professor Murray Maybery, have been identified as the world’s most frequent autism research collaborators of the decade.
The CliniKids team has reimagined how allied health services for children with autism spectrum disorder or developmental delays are delivered.
Video technology is helping researchers learn more about the early communication style of infants with a family history of autism, ADHD or intellectual disability.
To identify factors associated with quality of life (QoL) in children with intellectual disability. We aimed to identify patterns of association not observable in previous hypothesis-driven regression modelling using the same data set from a cross-sectional observational study.
Parents are often expected to be the primary implementers of intervention for their young children with autism spectrum disorder (ASD). The provision of a few hours a week of intervention by a trained therapist, in addition to parent-implemented intervention, could increase child outcomes compared to parent-implemented intervention in isolation.
The breadth of available non-pharmacological interventions for autistic children, with varying evidence for efficacy summarised in multiple systematic reviews, creates challenges for parents, practitioners, and policymakers in navigating the research evidence. In this article, we report the findings of an umbrella review of 58 systematic reviews of non-pharmacological interventions for autistic children (aged 0–12 years).